$38 Fargo - Season 1 [Blu-ray] Movies TV Blu-ray TV Season,$38,/Apostolos746022.html,Fargo,-,castleevents.com,Movies TV , Blu-ray , TV,1,[Blu-ray] Fargo - Season 1 Blu-ray Popular shop is the lowest price challenge $38 Fargo - Season 1 [Blu-ray] Movies TV Blu-ray TV Season,$38,/Apostolos746022.html,Fargo,-,castleevents.com,Movies TV , Blu-ray , TV,1,[Blu-ray] Fargo - Season 1 Blu-ray Popular shop is the lowest price challenge

Fargo - Season 1 Blu-ray Popular shop is the Same day shipping lowest price challenge

Fargo - Season 1 [Blu-ray]

$38

Fargo - Season 1 [Blu-ray]

|||

Editorial Reviews

The Coen Brothers' Best Picture Oscar nominee transforms into the season's most talked about TV debut. Fargo features a new "true crime" story and new characters...all chilled in the trademark dry wit, murderous mayhem and "Minnesota nice" of the original classic film. Oscar-winner Billy Bob Thornton stars as Lorne Malvo, a anipulative master criminal who changes the life of insurance salesman Lester Nygaard (Martin Freeman). Gus Grimly (Colin Hanks) and Molly Solverson (Allison Tolman) are the small-town police officers who join forces to uncover Lester's secrets and stop the relentlessly destructive Malvo. Episode List: 1. The Crocodile's Dilemma 2. The Rooster Prince 3. A Muddy Road 4. Eating the Blame 5. The Six Ungraspables 6. Buridan's Ass 7. Who Shaves the Barber? 8. The Heap 9. A Fox, A Rabbit, and A Cabbage 10. Morton's Fork Special features: Commentary by Billy Bob Thornton, Allison Tolman and Noah Hawley (on select episodes) This Is a True Story Greetings From Bemidji Shades of Green Deleted Scenes

Fargo - Season 1 [Blu-ray]

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA